Paysign, Inc. (NASDAQ:PAYS – Get Free Report) insider Matthew Louis Lanford sold 25,360 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $3.96, for a total value of $100,425.60. Following the completion of the sale, the insider now owns 109,731 shares of the company’s stock, valued at approximately $434,534.76. This trade represents a 18.77 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Paysign Trading Down 3.8 %
PAYS opened at $3.54 on Friday. The stock has a market cap of $189.57 million, a PE ratio of 23.60 and a beta of 0.95. Paysign, Inc. has a 1 year low of $2.22 and a 1 year high of $5.59. The stock’s 50 day simple moving average is $3.94 and its 200-day simple moving average is $4.34.
Paysign (NASDAQ:PAYS – Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.02. The business had revenue of $15.26 million for the quarter, compared to analysts’ expectations of $14.96 million. Paysign had a return on equity of 30.64% and a net margin of 14.28%. During the same period in the previous year, the business posted $0.02 earnings per share. Equities analysts forecast that Paysign, Inc. will post 0.21 earnings per share for the current fiscal year.
Institutional Trading of Paysign
Analyst Ratings Changes
Separately, Barrington Research restated an “outperform” rating and issued a $7.00 target price on shares of Paysign in a report on Monday, November 4th.
Read Our Latest Report on PAYS
Paysign Company Profile
Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.
Recommended Stories
- Five stocks we like better than Paysign
- Health Care Stocks Explained: Why You Might Want to Invest
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
- Airline Stocks – Top Airline Stocks to Buy Now
- Why Meta Should Rally All The Way Into 2025
- How to buy stock: A step-by-step guide for beginners
- 3 High-Yields Unfazed by the Election: Altria, Truist, Verizon
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.